RedHill Biopharma Reports Second Quarter 2019 Financial Results and Operational Highlights

    NEXT STORY
    Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy
    PREV STORY
    ChromaDex Appoints Scripps Research Professor of Molecular Medicine, Brunie H. Felding, PhD, to the Scientific Advisory Board
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AngioDynamics Reports Fiscal 2018 First Quarter Results

    Q1 net sales of $85.4 million, down 3% year-over-year            ...

    author_avatar
    NASDAQ Market News

    Point Of Care/Rapid Diagnostic Market, 2024

    author_avatar
    NASDAQ Market News

    Infusion Pumps Market to grow at a stellar pace reflecting a 5.4% CAGR by 2028 – Future Market Insights

    Smart Infusion Pumps with Detailed Drug Libraries to Dominate the Market; Transformative Technologies Adoption ...

    author_avatar
    NASDAQ Market News